Brief by Shorts91 Newsdesk / 06:15pm on 20 Mar 2024,Wednesday Health & Wellness
Indian pharmaceutical giant Dr. Reddy’s Laboratories has introduced Versavo (bevacizumab), a biosimilar of Roche’s cancer drug Avastin, in the United Kingdom. Versavo, indicated for various cancers, including colorectal and breast cancer, was initially launched in India in 2019. Its expansion into the UK market highlights Dr. Reddy’s commitment to providing global access to high-quality biosimilar products. Jayanth Sridhar, global head of biologics at Dr. Reddy’s, emphasized the significance of the launch, signaling the company's focus on oncology and meeting the unmet needs of patients worldwide.
